BCAX Stock Price
BCAX
$8.65
+$0.46(+5.62%)
30
Overall
60
Value
9
Tech
21
Quality
Market Cap
$541.96M
Volume
1.01M
52W Range
-- - --
Target Price
$34.08
BCAX stock price is $8.65 (+5.62% on the day), giving BCAX a market cap of $541.96M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
BCAX Stock Overview
- Price
- $8.65
- Previous close
- $8.19
- Open
- $8.32
- Market cap
- $541.96M
- 1-year price target
- $34.08
- MarketXLS Rank
- 30
About BCAX
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. The company's lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $8.65 | +5.6% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |